Skip to main content

Is Velcade a type of chemotherapy?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Oct 24, 2023.

Official answer

by drugclasses.com

Velcade is not a traditional form of chemotherapy (chemo). Velcade is a targeted drug therapy in the class of drugs known as proteasome inhibitors. Velcade is an injection often used as a first-line treatment of patients with multiple myeloma.

Targeted drug therapies work by blocking specific pathways that allow the cancer to grow uncontrolled. Because these drugs are "targeted", they may be linked with fewer, less severe or different side effects compared to traditional chemotherapy.

Chemotherapy works by killing rapidly growing cancer cells, but also can affect normal cells in the body. Chemotherapy is usually given in cycles, with rest periods, over several months.

Review more: Velcade side effects

How does Velcade work?

Velcade (bortezomib) is an injected medicine given to adults to treat multiple myeloma (a cancer of plasma cells) or mantle cell lymphoma (a cancer of the lymph nodes). It interferes with cancer cell growth and helps to keep it from spreading. It is given into your vein (intravenous) or as a subcutaneous (under the skin) injection. It is given with other medicines during your treatment cycles.

  • Velcade targets, blocks and slows down the action of proteasomes found inside cells. Proteasomes are protein complexes that break down unneeded or damaged proteins in cells, and some cancer cells are dependent on the proteasome to survive.
  • When Velcade blocks (targets) the proteasome, the cancer cell is unable to break down the unneeded proteins, which leads to cancer cell death.
  • Proteasome inhibitors have become an important class of medication for treatment of some types of cancer.

This is not all the information you need to know about Velcade (bortezomib) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Velcade information here, and discuss this medicine and any questions you have with your doctor or other health care provider.

Related questions

References

Read next

How long does it take for Jaypirca to work?

Jaypirca (pirtobrutinib) starts working quickly after you take it. However, it can take up to a few months for some people to see the full effects of the medication. In studies, patients taking Jaypirca saw their cancer shrink in size and stop spreading as early as 7 weeks for chronic lymphocytic leukemia and 3.5 weeks for mantle cell lymphoma. Continue reading

What is the success rate of Breyanzi?

Everyone will respond differently to Breyanzi (lisocabtagene maraleucel), and the success rate for someone else may be different than for you. Based on clinical trial data, the complete response rate in patients taking Breyanzi is around 20% to 73%, depending on the condition being treated. Continue reading

How much does Tecartus cost?

Tecartus costs $373,000 as a one time CAR-T immunotherapy cancer treatment. Most people do not pay for this medicine themselves. It is a personalized medicine engineered from a patient’s own white blood cells. Costs may be covered by your insurance plan, patient assistance programs, or financial resources offered through the manufacturer. Continue reading

Related medical questions

Drug information

Related support groups